BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16286413)

  • 1. Resection of an orbital lymphangioma with the aid of an intralesional liquid polymer.
    Malhotra AD; Parikh M; Garibaldi DC; Merbs SL; Miller NR; Murphy K
    AJNR Am J Neuroradiol; 2005; 26(10):2630-4. PubMed ID: 16286413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtotal excision with adjunctive sclerosing therapy for the treatment of severe symptomatic orbital lymphangiomas.
    Kahana A; Bohnsack BL; Cho RI; Maher CO
    Arch Ophthalmol; 2011 Aug; 129(8):1073-6. PubMed ID: 21825192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A variety of orbital lymphangioma treatments: one case treated with orbital decompression therapy and the other case with intralesional injection of OK-432 therapy].
    Oyama T; Eguchi K; Cho H; Abe H
    Nippon Ganka Gakkai Zasshi; 2009 Jul; 113(7):732-40. PubMed ID: 19637816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of orbital lymphangioma with intralesional bleomycin and application of continuous negative pressure.
    Lee KH; Han SH; Yoon JS
    Korean J Ophthalmol; 2015 Feb; 29(1):70-2. PubMed ID: 25646065
    [No Abstract]   [Full Text] [Related]  

  • 5. Sclerotherapy for Orbital Lymphangioma - Case Series and Literature Review.
    Patel KC; Kalantzis G; El-Hindy N; Chang BY
    In Vivo; 2017; 31(2):263-266. PubMed ID: 28358710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate.
    Poonyathalang A; Preechawat P; Jiarakongmun P; Pongpech S
    Jpn J Ophthalmol; 2008; 52(4):298-304. PubMed ID: 18773268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital decompression for gross proptosis associated with orbital lymphangioma.
    Hsuan J; Malhotra R; Davis G; Selva D
    Ophthalmic Plast Reconstr Surg; 2004 Nov; 20(6):463-5. PubMed ID: 15599249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit.
    Schwarcz RM; Ben Simon GJ; Cook T; Goldberg RA
    Am J Ophthalmol; 2006 Feb; 141(2):333-9. PubMed ID: 16458690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital lymphangiomas: a review of management strategies.
    Saha K; Leatherbarrow B
    Curr Opin Ophthalmol; 2012 Sep; 23(5):433-8. PubMed ID: 22828166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misleading presentation of an orbital lymphangioma.
    Nazarian-Mobin SS; Simms K; Urata MM; Tarczy-Hornoch K; Hammoudeh JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):e82-5. PubMed ID: 20031456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotradecol (sodium tetradecyl sulfate) injection of orbital lymphangioma.
    Wojno TH
    Ophthalmic Plast Reconstr Surg; 1999 Nov; 15(6):432-7. PubMed ID: 10588254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined surgical and sclerotherapy for an extensive venous-lymphatic orbital anomaly.
    Tandon A; Jones S; Valenzuela AA
    J AAPOS; 2013 Aug; 17(4):434-6. PubMed ID: 23871137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional injection of OK-432 for vision-threatening orbital lymphangioma.
    Yoon JS; Choi JB; Kim SJ; Lee SY
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):1031-5. PubMed ID: 17577592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital Lymphangioma: Characteristics and Treatment Outcomes of 12 Cases.
    Woo YJ; Kim CY; Sgrignoli B; Yoon JS
    Korean J Ophthalmol; 2017 Jun; 31(3):194-201. PubMed ID: 28534344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orbital lymphangioma: a clinical and radiological entity. Apropos of a case].
    Lewden O; Garcher C; Desvaux C; Couailler JF; Bron A
    J Fr Ophtalmol; 1995; 18(1):56-9. PubMed ID: 7738298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of orbital lymphangioma using intralesional injection of OK-432.
    Suzuki Y; Obana A; Gohto Y; Miki T; Otuka H; Inoue Y
    Br J Ophthalmol; 2000 Jun; 84(6):614-7. PubMed ID: 10837387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of orbital lymphangioma with persistent fetal vasculature and extraorbital vascular malformations treated with intralesional bleomycin.
    Hada M; Upadhyay A; Khilnani K; Shekhawat N
    J AAPOS; 2018 Dec; 22(6):471-473.e1. PubMed ID: 30120984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative management of childhood orbital lymphangioma.
    Wilson ME; Parker PL; Chavis RM
    Ophthalmology; 1989 Apr; 96(4):484-9. PubMed ID: 2726177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sclerotization of orbital lymphangioma with OK-432].
    Lagrèze W; Metzger M; Rössler J
    Ophthalmologe; 2014 May; 111(5):479-81. PubMed ID: 24706253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional bleomycin: a potential treatment for refractory orbital lymphangiomas.
    Gooding C; Meyer D
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):e65-7. PubMed ID: 24025999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.